Skip to main content

Table 1 Volume and dose comparisons among plans generated from 3D-CRT with FB, T-DIBH and A-DIBH

From: Abdominal DIBH reduces the cardiac dose even further: a prospective analysis

  3D-CRT plans P value
Parameters FB T-DIBH A-DIBH FB v.s. T FB v.s.A T v.s. A
PTV
 Volume (cm3) 674.14±244.51 673.77±249.54 673.81±246.49 N.S. N.S. N.S.
 Mean (Gy) 51.61±14.37 51.41±14.65 51.46±13.63 N.S. N.S. N.S.
 D2% (Gy) 53.88±15.13 53.76±15.37 53.83±13.84 N.S. N.S. N.S.
 V105% (%) 26.58±22.70 26.51±21.17 26.55±19.27 N.S. N.S. N.S.
 HI (%) 15.49±1.95 15.34±1.89 15.46±1.72 N.S. N.S. N.S.
Heart
 Volume (cm3) 549.54±88.01 504.83±69.55 479.53±74.44 ** *** *
 Mean (Gy) 2.89±1.30 1.67±0.90 1.34±0.43 *** *** ***
 D2% (Gy) 31.25±16.99 12.11±13.22 6.53±4.05 *** *** ***
 V5 (%) 7.78±4.20 3.68±3.21 2.57±2.05 *** *** **
 V10 (%) 4.57±3.07 1.65±2.14 0.93±1.17 *** *** **
 V20 (%) 3.26±2.62 1.05±1.68 0.53±0.77 *** *** *
 V30 (%) 2.62±2.26 0.78±1.40 0.36±0.57 *** *** *
LADCA
 Volume (cm3) 0.80±0.12 0.80±0.13 0.80±0.10 N.S. N.S. N.S.
 Mean (Gy) 29.08±16.72 13.94±14.74 10.22±10.30 *** *** ***
 D2% (Gy) 37.59±17.58 22.03±18.02 18.45±16.52 *** *** **
 V5 (%) 87.69±24.39 54.94±39.17 49.42±40.11 *** *** *
 V10 (%) 66.02±37.45 32.36±39.20 26.41±37.24 *** *** *
 V20 (%) 57.39±41.18 23.37±36.48 18.22±31.57 *** *** *
 V30 (%) 52.94±40.24 19.10±34.19 12.55±25.01 *** *** N.S.
Left lung
 Volume (cm3) 1022.22±223.48 1541.81±324.32 1663.36±270.93 *** *** N.S.
 Mean (Gy) 7.77±2.71 7.32±1.42 6.90±1.60 * * *
 D2% (Gy) 46.67±5.06 46.16±2.89 45.31±3.01 * ** ***
 V5 (%) 25.53±7.35 25.84±4.13 24.94±4.80 N.S. N.S. N.S.
 V10 (%) 17.63±6.23 16.99±3.36 15.96±4.05 N.S. N.S. *
 V20 (%) 13.37±5.77 12.32±3.09 11.26±3.68 N.S. * *
 V30 (%) 11.34±5.62 10.29±3.15 9.28±3.48 N.S. * **
  1. Note: * <0.05, ** <0.01,*** <0.001, N.S.: not significant